Observational Cohort Study of Advanced Non-small Cell Lung Cancer (CAPTRA-LUNG)
NCT ID: NCT03334864
Last Updated: 2023-09-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
5000 participants
OBSERVATIONAL
2022-11-03
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Study type: Observational (Patient Registry)
Study design: Observational Model: Cohort
Time Perspective: Prospective and retrospective
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Circulating Tumor DNA Longitudinal Monitoring in Stage III-IV Lung Cancer Patients
NCT03664843
Clinical Application of MR-PET in Non-small Cell Lung Cancer: Diagnosis, Treatment Outcome, and Prognosis Prediction
NCT03053804
Factors Determining the Prognosis in NSCLC Stage IV
NCT04306094
Survival Outcomes of Lung Cancer
NCT03647098
Real-world Clinical Outcomes of Patients With Early-stage Lung Cancer After the Surgery
NCT06483698
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
I Retrospective cohort
Diagnosis of advanced non-small cell lung cancer from 2012-2016
No interventions assigned to this group
II Prospective cohort
Advanced non-small cell lung cancer with driver gene mutations
No interventions assigned to this group
III Prospective cohort
Non-small cell lung cancer in immuno-therapy;
No interventions assigned to this group
IV Prospective cohort
Non-small cell lung cancer with wild-type driver gene or unknown driver gene status;
No interventions assigned to this group
V Prospective cohort
Advanced non-small lung cancer with wild-type gene treated with anti-Vascular Endothelial Growth Factor (VEGF) drug.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Cohort II: documented positive driver gene mutations; and diagnosis of advanced non-small cell lung cancer;
* Cohort III: diagnosis of advanced non-small cell lung cancer and in immune-therapy;
* Cohort IV: diagnosis of advanced non-small cell lung cancer, and with wild-type driver gene or unknown driver gene status;
* Cohort V: treated with anti-VEGF drug in first line, diagnosis of advanced non-squamous and non-small cell lung cancer in 6 months before recruit;
* Age\>18 years;
* Provision of written informed consent.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peking Union Medical College Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Yan Xu, Dr.
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Xu Y, Zhang L, Fang J, Wang Z, Li J, Li L, Ai B, Nie L, Mu X, Liang L, Zhang S, Zhang Y, Song Y, Song X, Wang Y, Xin T, Jin B, Wang X, Ding C, Wang M. Establishment of a prospective multicenter cohort for advanced non-small cell lung cancer in China (CAPTRA-Lung study). Thorac Cancer. 2018 Dec;9(12):1795-1800. doi: 10.1111/1759-7714.12865. Epub 2018 Sep 27.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
JS-1410
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.